Not logged in Four-year outcomes from GEMSTONE-302 study: First-line sugemalimab plus platinum-based chemotherapy in metastatic non-small cell lung cancer (NSCLC) Zhou, C.; Wang, Z.; Sun, M.; Cao, L.; Ma, Z.; Wu, R.; Yu, Y.; Yao, W.; Sun, S.; Chen, J.; Zhuang, W.; Cui, J.; Chen, X.; Lu, Y.; Hu, C.; Wang, J.; Wang, Q.; Wang, B.; Dai, H.; Yang, J. J. Share Save
Updated efficacy and safety results from phase III SPOTLIGHT study evaluating zolbetuximab+mFOLFOX6 as first-line (1L) treatment for patients with claudin-18 isoform 2-positive (CLDN18.2+), HER2L, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma Ajani, J. A.; Lordick, F.; Bang, Y-J.; Enzinger, P. C.; Ilson, D. H.; Shah, M. A.; van Cutsem, E.; Xu, R-H.; Aprile, G.; Xu, J.; Pazo Cid, R. A.; Kang, Y-K.; Yang, J.; Moran, D.; Bhattacharya, P.; Matsangou, M.; Arozullah, A.; Park, J. W.; Shitara, K. Share Save
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2-Positive Gastric or Gastroesophageal Junction Adenocarcinoma Klempner, Samuel J.; Lee, Keun-Wook; Shitara, Kohei; Metges, Jean-Phillippe; Lonardi, Sara; Ilson, David H.; Fazio, Nicola; Kim, Tae Yong; Bai, Li-Yuan; Moran, Diarmuid; Yang, Jianning; Arozullah, Ahsan; Park, Jung Wook; Raizer, Jeffrey J.; Bang, Yung-Jue; Shah, Manish A. Share Save
Share Save
GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an antiPDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC) Zhou, C.; Wang, Z.; Sun, Y.; Cao, L.; Ma, Z.; Wu, R.; Yu, Y.; Yao, W.; Chang, J.; Chen, J.; Zhuang, W.; Cui, J.; Chen, X.; Lu, Y.; Shen, H.; Li, P.; Wang, J.; Sun, B.; Lu, D.; Yang, J. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
.png){kind=icon}
Share.png){kind=icon}
Save